Get started
Author

Ping’an Ding

Observed names: Ding, Ping’an, P A Ding, Ping'an Ding, Ping-An Ding, Pingan Ding
ORCID: 0000-0002-8163-0711
Observed ORCID: 0000-0002-8163-0711
OpenAlex ID: A5006333779
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
2024 · Lingjiao Meng, Haotian Wu, et al. · Cell Death and Disease · 199
PDF
Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study
2022 · Ping’an Ding, Honghai Guo, et al. · BMC Gastroenterology · 183
PDF
Circular RNA ciRS-7 accelerates ESCC progression through acting as a miR-876-5p sponge to enhance MAGE-A family expression
2018 · Meixiang Sang, Lingjiao Meng, et al. · Cancer Letters · 149
Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs
2018 · Meixiang Sang, Lingjiao Meng, et al. · Molecular Cancer Research · 91
Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
2018 · Yishui Lian, Lingjiao Meng, et al. · Clinical Epigenetics · 78
PDF
Circular RNA ciRS‐7 inhibits autophagy of ESCC cells by functioning as miR‐1299 sponge to target EGFR signaling
2019 · Lingjiao Meng, Sihua Liu, et al. · Journal of Cellular Biochemistry · 65
Phase angle derived from bioelectrical impedance analysis as a marker for predicting sarcopenia
2022 · Haotian Wu, Ping'an Ding, et al. · Frontiers in Nutrition · 59
PDF
Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A expression
2022 · Lingjiao Meng, Sheng Chang, et al. · Breast Cancer Research · 59
PDF
Sarcopenia: Molecular regulatory network for loss of muscle mass and function
2023 · Jiaxiang Wu, Ping’an Ding, et al. · Frontiers in Nutrition · 55
PDF
Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial
2022 · Honghai Guo, Ping’an Ding, et al. · Frontiers in Oncology · 49
PDF
Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study
2022 · Ping’an Ding, Peigang Yang, et al. · Frontiers in Oncology · 43
PDF
N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs/VEGFA signaling in gastric cancer
2024 · Ping’an Ding, Haotian Wu, et al. · Oncogene · 42
Combined systemic inflammatory immunity index and prognostic nutritional index scores as a screening marker for sarcopenia in patients with locally advanced gastric cancer
2022 · Ping'an Ding, Jingxia Lv, et al. · Frontiers in Nutrition · 40
PDF
Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer
2025 · Ping'an Ding, Jiaxuan Yang, et al. · Advanced Science · 34
Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
2022 · Ping’an Ding, Honghai Guo, et al. · Frontiers in Nutrition · 34
PDF
Assessment of Carbon Nanoparticle Suspension Lymphography–Guided Distal Gastrectomy for Gastric Cancer
2022 · Yuan Tian, Peigang Yang, et al. · JAMA Network Open · 31
Lymphangiogenesis in gastric cancer: function and mechanism
2023 · Pengpeng Liu, Ping’an Ding, et al. · European journal of medical research · 28
PDF
Circular RNA circ‐TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR ‐452‐5p/ DAG1 axis
2023 · Ruiyu Xu, Pingan Ding, et al. · Molecular Oncology · 28
PDF
Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial
2023 · Yuan Tian, Peigang Yang, et al. · International Journal of Surgery · 26
A deep learning–based digital biopsy for predicting early recurrence in gastric cancer
2026 · Ping’an Ding, Sheng Chen, et al. · Nature Communications · 25
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective study
2021 · Ping’an Ding, Peigang Yang, et al. · Journal of Gastrointestinal Oncology · 24
PDF
Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric Cancer
2025 · Ping'an Ding, Jiaxuan Yang, et al. · Advanced Science · 23
Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective study
2024 · Ping’an Ding, Jiaxuan Yang, et al. · BMC Cancer · 23
Mechanisms and biomarkers of immune-related adverse events in gastric cancer
2023 · Ping’an Ding, Pengpeng Liu, et al. · European journal of medical research · 23
PDF
The inflammatory burden index: A promising prognostic predictor in patients with locally advanced gastric cancer
2023 · Ping'an Ding, Haotian Wu, et al. · Clinical Nutrition · 23
Works count: 130
Citation count: 2,004
H-index: 23
I10-index: 53
Year
Topic
Type